*ST康美,600518,收入构成,报告日期,2021-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 医药工业和商业,174279,146270,28009,16.07%,72.63% 物业租售及其他,22865,13926,8939,39.09%,23.18% 保健食品及食品,9799,8185,1614,16.47%,4.19% *ST康美,600518,收入构成,报告日期,2020-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 中药,159033,137042,21991,13.83%,102.89% 医疗器械,136622,179565,-42943,-31.43%,-200.92% 西药,170941,151779,19162,11.21%,89.65% 物业租售及其他,41450,33954,7496,18.09%,35.07% 其他(补充),14452,2783,11669,80.74%,54.6% 保健食品及食品,18702,14705,3998,21.38%,18.7% *ST康美,600518,收入构成,报告日期,2020-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 医药工业和商业,213652,175023,38629,18.08%,76.06% 物业租售及其他,29528,19614,9915,33.58%,19.52% 保健食品及食品,8501,6259,2242,26.37%,4.41% *ST康美,600518,收入构成,报告日期,2019-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 医药工业和商业,928107,823595,104511,11.26%,69.19% 物业租售及其他,170837,142728,28109,16.45%,18.61% 其他(补充),11618,1468,10149,87.36%,6.72% 保健食品及食品,33993,25717,8276,24.35%,5.48% *ST康美,600518,收入构成,报告日期,2019-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 物业租售及其他,143368,99091,44277,30.88%,16.83% 西药,280158,191377,88781,31.69%,33.74% 其他(补充),6595,764,5831,88.41%,2.22% 医疗器械,177176,125111,52065,29.39%,19.79% 食品及保健食品,62085,53195,8891,14.32%,3.38% 中药,143885,80608,63277,43.98%,24.05% *ST康美,600518,收入构成,报告日期,2018-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他(补充),25222,2014,23207,92.01%,3.99% 保健食品,37183,16880,20303,54.6%,3.49% 自制药品,4333,2578,1755,40.51%,0.3% 食品,110966,110241,725,0.65%,0.12% 药品贸易,793798,540287,253511,31.94%,43.6% 中药饮片,414174,289674,124500,30.06%,21.41% 物业租售及其他,111833,49518,62314,55.72%,10.72% 医疗器械,377892,287625,90267,23.89%,15.53% 中药材贸易,60223,55423,4800,7.97%,0.83% *ST康美,600518,收入构成,报告日期,2018-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 医疗器械,134504,95249,39255,29.19%,7.67% 药品贸易,490443,348434,142009,28.96%,27.76% 其他(补充),7763,903,6861,88.37%,1.34% 保健食品,61737,34786,26951,43.65%,5.27% 自制药品,13411,11232,2179,16.25%,0.43% 中药饮片,382682,243403,139279,36.4%,27.22% 物业租售及其他,80131,51081,29050,36.25%,5.68% 中药材贸易,480266,356736,123530,25.72%,24.15% 食品,44995,42504,2491,5.54%,0.49% *ST康美,600518,收入构成,报告日期,2017-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 自制药品,11858,8634,3225,27.19%,0.4% 药品贸易,959879,673311,286568,29.85%,35.7% 食品,78280,76242,2038,2.6%,0.25% 物业租售及其他,78185,36670,41515,53.1%,5.17% 医疗器械,199010,140223,58787,29.54%,7.32% 中药材贸易,585693,442370,143323,24.47%,17.86% 中药饮片,615845,406486,209359,34%,26.08% 保健食品,107779,59832,47947,44.49%,5.97% 其他(补充),11167,1246,9922,88.84%,1.24% *ST康美,600518,收入构成,报告日期,2017-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他(补充),4056,872,3183,78.49%,1.04% 物业租售及其他,48290,26126,22164,45.9%,7.26% 食品,33099,30751,2348,7.09%,0.77% 保健食品,57553,32131,25422,44.17%,8.32% 医疗器械,80175,55599,24577,30.65%,8.05% 药品贸易,445272,313291,131980,29.64%,43.22% 自制药品,7501,5688,1813,24.17%,0.59% 中药材贸易,380571,286672,93900,24.67%,30.75% *ST康美,600518,收入构成,报告日期,2016-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他(补充),6658,777,5881,88.32%,0.91% 物业租售及其他,94317,51915,42402,44.96%,6.55% 食品,70684,70018,666,0.94%,0.1% 保健食品,102780,58724,44056,42.86%,6.81% 医疗器械,91340,69658,21682,23.74%,3.35% 药品贸易,730290,508397,221893,30.38%,34.29% 自制药品,18937,14417,4520,23.87%,0.7% 中药材贸易,578868,439242,139626,24.12%,21.58% 中药饮片,470358,304005,166354,35.37%,25.71% *ST康美,600518,收入构成,报告日期,2016-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他(补充),2254,488,1766,78.35%,0.55% 物业租售及其他,41338,22599,18740,45.33%,5.83% 食品,29553,29145,407,1.38%,0.13% 保健食品,50022,27739,22282,44.55%,6.93% 医疗器械,35770,28422,7348,20.54%,2.29% 药品贸易,353579,252661,100919,28.54%,31.39% 自制药品,11215,8811,2404,21.43%,0.75% 中药材贸易,398018,300551,97467,24.49%,30.31% 中药饮片,198600,128385,70215,35.36%,21.84% *ST康美,600518,收入构成,报告日期,2015-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他(补充),7265,1002,6263,86.2%,1.22% 物业租售及其他,64465,30461,34004,52.75%,6.64% 食品,58858,58465,394,0.67%,0.08% 保健食品,81898,45202,36696,44.81%,7.17% 医疗器械,59392,47064,12328,20.76%,2.41% 药品贸易,539538,396184,143353,26.57%,28% 自制药品,20380,16111,4269,20.95%,0.83% 中药材贸易,602853,459656,143197,23.75%,27.97% 中药饮片,372033,240582,131451,35.33%,25.68% *ST康美,600518,收入构成,报告日期,2015-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他(补充),1490,339,1151,77.25%,0.27% 其中:医药器械,26871,21191,5680,21.14%,1.34% 保健食品及食品,61395,44901,16494,26.87%,3.9% 西药,283671,211026,72645,25.61%,17.18% 其中:中药材贸易,376021,280082,95939,25.51%,22.69% 物业租售及其他,35408,16549,18859,53.26%,4.46% 其中:药品贸易,244937,180141,64796,26.45%,15.32% 中药,524549,377241,147308,28.08%,34.84% *ST康美,600518,收入构成,报告日期,2014-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他(补充),4180,43,4137,98.97%,0.6% 其中:医药器械,43622,33841,9781,22.42%,1.41% 其中:中药材贸易,716145,542338,173807,24.27%,25.05% 物业租售及其他,63548,45617,17931,28.22%,2.58% 保健食品及食品,87954,68256,19698,22.4%,2.84% 西药,443143,337127,106016,23.92%,15.28% 其中:药品贸易,377580,285504,92076,24.39%,13.27% 中药,996094,725779,270316,27.14%,38.96% *ST康美,600518,收入构成,报告日期,2014-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其中:中药材贸易,365890,273891,91999,25.14%,26.17% 保健食品及食品,35966,28704,7262,20.19%,2.07% 其中:药品贸易,203829,150501,53328,26.16%,15.17% 西药,216003,160518,55485,25.69%,15.78% 中药,494549,360386,134162,27.13%,38.17% 其他(补充),1758,-- ,-- ,--,0% 物业租售及其他,27917,18621,9296,33.3%,2.64% *ST康美,600518,收入构成,报告日期,2013-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他(补充),1483,7,1476,99.5%,0.24% 物业租售及其他,35731,20251,15480,43.32%,2.53% 食品,39950,35011,4939,12.36%,0.81% 其中:药品贸易,246349,192376,53973,21.91%,8.84% 西药,269064,210602,58463,21.73%,9.57% 其中:中药材贸易,809211,601044,208167,25.72%,34.08% 中药,989644,721397,268247,27.11%,43.92% *ST康美,600518,收入构成,报告日期,2013-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他(补充),529,-- ,-- ,--,0% 物业租售及其他,30028,16564,13464,44.84%,7.96% 食品,19309,17364,1944,10.07%,1.15% 西药,119151,96055,23096,19.38%,13.66% 中药,441558,310984,130574,29.57%,77.23% *ST康美,600518,收入构成,报告日期,2013-03-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 物业租售及其他,15100,8200,6900,45.7%,4.2% 食品,10100,9600,500,4.95%,0.3% 其中:药品贸易,52700,42100,10600,20.11%,6.46% 西药,59100,47300,11800,19.97%,7.19% 其中:中药材贸易,200500,140700,59800,29.83%,36.44% 中药,247400,172900,74500,30.11%,45.4% *ST康美,600518,收入构成,报告日期,2012-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他(补充),946,18,928,98.06%,0.33% 物业租售及其他,29191,17460,11731,40.19%,4.18% 食品,25330,21473,3857,15.23%,1.37% 西药,190731,158564,32166,16.86%,11.45% 中药,870318,638091,232227,26.68%,82.67% *ST康美,600518,收入构成,报告日期,2012-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 食品,14492,12379,2112,14.58%,1.6% 中药,419013,301942,117070,27.94%,88.54% 其他(补充),383,-- ,-- ,--,0% 物业管理,1341,522,819,61.06%,0.62% 西药,76103,63883,12220,16.06%,9.24% *ST康美,600518,收入构成,报告日期,2011-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 物业管理,2587,864,1723,66.61%,0.94% 食品,13104,10482,2622,20.01%,1.43% 西药,96379,76667,19712,20.45%,10.74% 中药,495579,336514,159065,32.1%,86.68% 其他(补充),401,12,389,96.94%,0.21% *ST康美,600518,收入构成,报告日期,2011-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他(补充),127,-- ,-- ,--,0% 物业管理,1023,374,648,63.39%,0.77% 食品,10616,8995,1621,15.27%,1.92% 中药,212019,140340,71679,33.81%,84.97% 西药,55457,45050,10408,18.77%,12.34% *ST康美,600518,收入构成,报告日期,2010-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他(补充),1179,905,274,23.2%,0.23% 物业管理,1560,642,919,58.87%,0.76% 中药材贸易,132833,74167,58666,44.17%,48.57% 药品贸易,50059,42522,7537,15.06%,6.24% 食品,9014,7643,1370,15.2%,1.13% 新开河产品,9367,5366,4001,42.71%,3.31% 中药饮片,100076,61792,38284,38.25%,31.7% 自制药品,26792,17064,9728,36.31%,8.05% *ST康美,600518,收入构成,报告日期,2010-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 食品,3535,3027,507,14.35%,0.95% 新开河产品,4100,2252,1847,45.06%,3.45% 中药饮片,48181,30258,17923,37.2%,33.5% 外购产品,77942,49496,28446,36.5%,53.17% 其他,509,137,372,73.12%,0.7% 利乐,2981,1968,1013,33.99%,1.89% 诺沙,3007,2179,828,27.53%,1.55% 络欣平,2900,1395,1505,51.9%,2.81% 培宁,1728,673,1054,61.03%,1.97% *ST康美,600518,收入构成,报告日期,2009-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 外购产品,120053,86386,33667,28.04%,42.73% 新开河产品,3724,2276,1448,38.89%,1.84% 中药饮片,87030,53267,33763,38.79%,42.85% 培宁,3628,1376,2253,62.09%,2.86% 络欣平,6086,2736,3350,55.05%,4.25% 康美诺沙,6298,4222,2076,32.96%,2.64% 康美利乐,6355,4124,2230,35.1%,2.83% *ST康美,600518,收入构成,报告日期,2009-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 中药饮片,43797,27027,16770,38.29%,80.96% 利乐,3386,2201,1185,35%,5.72% 诺沙,3207,2128,1080,33.66%,5.21% 络欣平,3044,1365,1678,55.14%,8.1% *ST康美,600518,收入构成,报告日期,2008-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 中药饮片,62824,38941,23883,38.02%,70.4% 康美利乐,6609,4226,2382,36.05%,7.02% 康美诺沙,6185,4039,2146,34.69%,6.32% 络欣平,5970,2623,3347,56.06%,9.86% 培宁,3565,1398,2168,60.8%,6.39% *ST康美,600518,收入构成,报告日期,2008-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 中药饮片,29357,18286,11071,37.71%,73.67% 利乐,3277,2065,1212,36.98%,8.06% 诺沙,3127,2010,1117,35.71%,7.43% 络欣平,2882,1255,1628,56.47%,10.83% *ST康美,600518,收入构成,报告日期,2007-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 外购中药材,41604,35675,5929,14.25%,20.13% 中药饮片,35031,21989,13041,37.23%,44.28% 培宁,3461,1358,2104,60.78%,7.14% 络欣平,6519,2884,3635,55.76%,12.34% 康美诺沙,6478,4211,2267,35%,7.7% 康美利乐,6669,4196,2473,37.08%,8.4% *ST康美,600518,收入构成,报告日期,2007-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 中药饮片,14599,9185,5413,37.08%,56.75% 利乐,3466,2191,1275,36.79%,13.37% 诺沙,3306,2185,1121,33.91%,11.75% 络欣平,3120,1390,1730,55.46%,18.14% *ST康美,600518,收入构成,报告日期,2006-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 外购产品,31712,27271,4441,14%,18.46% 中药饮片,23474,15038,8437,35.94%,35.06% 自产产品,27374,16188,11186,40.87%,46.49% *ST康美,600518,收入构成,报告日期,2006-09-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 外购药品,14933,12744,2189,14.66%,13.45% 中药材贸易,4229,3805,425,10.04%,2.61% 中药饮片,17664,11412,6252,35.4%,38.44% 利乐,5378,3319,2059,38.29%,12.66% 诺沙,6353,3827,2526,39.76%,15.53% 络欣平,4832,2016,2815,58.27%,17.31% *ST康美,600518,收入构成,报告日期,2006-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 外购产品,9424,8068,1356,14.39%,12.2% 中药饮片,11235,7300,3936,35.03%,35.41% 自产产品,13774,7953,5821,42.26%,52.38% *ST康美,600518,收入构成,报告日期,2006-03-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 中药饮片,4782,3130,1652,34.55%,42.11% 利乐,1806,1110,696,38.56%,17.75% 诺沙,1849,1113,736,39.81%,18.76% 络欣平,1445,606,839,58.08%,21.39% *ST康美,600518,收入构成,报告日期,2005-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 外购产品,16685,14290,2395,14.36%,13.06% 中药饮片,17592,11498,6094,34.64%,33.22% 自产产品,24184,14328,9856,40.75%,53.72% *ST康美,600518,收入构成,报告日期,2005-09-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 中药饮片,13291,8669,4622,34.78%,40.3% 利乐,5244,3257,1987,37.88%,17.32% 诺沙,6022,3593,2429,40.34%,21.18% 络欣平,4238,1806,2432,57.39%,21.2% *ST康美,600518,收入构成,报告日期,2005-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 外购产品,7772,6656,1117,14.37%,12.62% 诺沙,4086,2412,1674,40.96%,18.91% 中药饮片,9051,5881,3170,35.02%,35.8% 利乐,3506,2181,1326,37.8%,14.97% 络欣平,2733,1166,1567,57.34%,17.7% *ST康美,600518,收入构成,报告日期,2005-03-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 中药饮片,4472,2927,1545,34.54%,44.29% 利乐,1583,1001,582,36.78%,16.7% 诺沙,1609,945,664,41.28%,19.04% 络欣平,1202,505,697,57.99%,19.98% *ST康美,600518,收入构成,报告日期,2004-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 外购经营药品,15862,0,15862,100%,48.58% 其他自产产品,2493,0,2493,100%,7.64% 中药饮片,15898,10519,5379,33.83%,16.47% 利乐,7525,4764,2762,36.7%,8.46% 诺沙,7716,4701,3015,39.08%,9.23% 络欣平,5817,2679,3138,53.94%,9.61% *ST康美,600518,收入构成,报告日期,2004-09-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 中药饮片,11590,7711,3879,33.47%,37.79% 利乐,5290,3359,1931,36.51%,18.81% 诺沙,5809,3539,2270,39.07%,22.11% 络欣平,4135,1950,2185,52.84%,21.29% *ST康美,600518,收入构成,报告日期,2004-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 中药饮片,6573,4468,2105,32.03%,33.61% 利乐,3515,2242,1273,36.22%,20.33% 诺沙,3801,2315,1485,39.08%,23.71% 络欣平,2683,1284,1400,52.17%,22.35% *ST康美,600518,收入构成,报告日期,2004-03-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 中药饮片,2322,1620,702,30.25%,29.36% 利乐,1453,923,529,36.44%,22.12% 诺沙,1492,911,582,38.97%,24.31% 络欣平,1104,524,579,52.49%,24.21% *ST康美,600518,收入构成,报告日期,2003-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 外购产品,15739,13496,2243,14.25%,17.37% 中药饮片,6540,4823,1716,26.25%,13.29% 自产产品,24169,15217,8952,37.04%,69.33% *ST康美,600518,收入构成,报告日期,2003-09-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 康美利乐,5430,3585,1845,33.97%,29.47% 康美诺沙,5962,3717,2245,37.65%,35.87% 康美络欣平,4081,1911,2170,53.17%,34.66% *ST康美,600518,收入构成,报告日期,2003-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 外购产品,7634,6609,1025,13.43%,17.12% 中药饮片,2903,2204,699,24.08%,11.67% 康美利乐,3546,2367,1180,33.26%,19.7% 康美诺沙,4218,2635,1584,37.54%,26.45% 康美络欣平,2818,1318,1500,53.23%,25.05% *ST康美,600518,收入构成,报告日期,2002-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 药品,41098,0,41098,100%,100% *ST康美,600518,收入构成,报告日期,2002-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 康美络欣平,2123,1353,770,36.27%,21.85% 康美利乐,3974,2646,1328,33.42%,37.7% 康美诺沙,4031,2606,1425,35.35%,40.44% *ST康美,600518,收入构成,报告日期,2001-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他,5437,0,5437,100%,14.28% 外购产品,11373,0,11373,100%,29.87% 康美络欣平,3806,0,3806,100%,9.99% 康美诺沙,8993,0,8993,100%,23.62% 康美利乐,8470,0,8470,100%,22.24%